Prevention of earring infection in the intensive care ward.

The ICSU focuses on the treatment of persons with acute illnesses due to their acute condition, low immune capacity and high levels of intrusive operation. As an emerging drug-resistant fungus, ICU infection prevention and control is a major challenge, which can be easily transmitted, drug-resistant and can cause serious infections, increase patient mortality and prevent and control. An overview of the infection is the fungus found in Japan in 2009, with high resistance rates to commonly used antifluorinated drugs such as fluoride and voltacin. In the ICU environment, patients have a permanent use of broad-spectral antibiotics, sugar-coated hormones, central veins, gas tube intubation, etc., to destroy the institutional barriers, so as to make the eardrum fungible and, in case of infection, to attack blood, urine roads, lungs, etc., cause heat, cold warfare, organ function disorders, and treatment difficulties. 1. Monitoring and screening: the establishment of active monitoring mechanisms for new arrivals to the ICU and patients who have been hospitalized for an excessive period of time (e.g., 7 days), the collection of specimens such as swabs, sorbs, blood, urine, fluids, and the screening of earring fungus by professional culture, molecular biology, at least 1 per week, dynamically tracked. If a person is identified with a plant or infection, the person is immediately isolated and reported. 2. Infection prevention and control measures: isolation of patients who have been diagnosed or suspected of being infected, separation of the same infections from the same room when the conditions are met, bed spacing of 1 metre, segregation markings, restricted access, specialized care of medical personnel, final medical care and reduced cross-section. Handi-sanitation: People in frequent contact, such as medical care, cleaning and family members, are strictly hand-sanitated, hand-washing is carried out with alcohol-containing hand-washing or soap-flowing water, with a “seven-step hand-washing” of 20 seconds, hand-washing before, after, after and after exposure, with gloves off, and hand-releases are provided at the entrance to the ward and next to the hospital bed to facilitate access. Personal protective equipment: Access to the isolation wards with protective clothing, medical masks, gloves, operation with the potential to spray glasses or screens, timely replacement of protective supplies, de-loading to avoid secondary contamination. Environmental cleaning: End-of-day disinfection of wards, cleaning of bed bars, bed-head cabinets, equipment surfaces, etc. with chlorine-containing disinfectants (effective chlorine 1000 mg/L), wet cleaning, disinfection of ground floors; treatment of reused devices by disinfection process, non-resistant of high temperature high pressure to select low temperature plasma, ethylene oxide sterilisation; air disinfection with ultraviolet radiation or air disinfector, regular maintenance to ensure effects. 3. Rational use of antibacterial drugs: establishment of multidisciplinary teams of specialists in infectious, acute and clinical pharmacological sciences, with periodic assessments based on the patient ‘ s condition, his or her sensitivity and accuracy, lowering or decommissioning of the ladder, reducing unnecessary exposure to antibacterial drugs and reducing the risk of resistance. Training and education Regular training of all ICU personnel, including doctors, nurses, nurses, logistics personnel. They include knowledge of the epidemiology, up-to-date guidelines on prevention and control, operational skills, post-training examinations and qualified induction; and teaching family members about the risk of infection, the importance of protection, such as visitation restrictions, hand-washing, and the distribution of brochures, live demonstrations and increased compliance. The control of ICU patients requires multi-stage coordination, monitoring, isolation, hand hygiene, environmental disinfection, rational use of medicines and training. In the future, with technological advances, the development of new types of anti-facter drugs and rapid diagnostic reagents, combined with large data and artificial intelligence to optimize early warning models for the prediction of infections, is expected to be more accurate and effective in the prevention and control of those infected with ICU, to establish secure lines of defence, to improve success and reduce the risk of infection.